Serum miR-21 level: A potential diagnostic and prognostic biomarker for non-small cell lung cancer

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 9, 2015, Pages 14759-14763

  Zhao, Wei ^a   Zhao, Jun Jie ^a   Zhang, Long ^a   Xu, Qin Fu ^a   Zhao, Yu Miao ^a   Shi, Xiao Ya ^a   Xu, Ai Guo ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Diagnosis; MiR 21; Non small cell lung cancer; Prognosis; Serum

Indexed keywords

MICRORNA 21;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; SURVIVAL TIME;

EID: 84946554185     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Cersosimo RJ. Lung cancer: a review. Am J Health Syst Pharm 2002; 59: 611-642.
2. Rezaei MK, Nolan NJ, Schwartz AM. Surgical pathology of lung cancer. Semin Respir Crit Care Med 2013; 34: 770-786.
3. Du L, Pertsemlidis A. Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation. J Mol Cell Biol 2011; 3: 176-180.
4. Chan B, Manley J, Lee J, Singh SR. The emerging roles of microRNAs in cancer metabolism. Cancer Lett 2015; 356: 301-308.
5. Ibrahim SA, Hassan H, Götte M. MicroRNA regulation of proteoglycan function in cancer. FEBS J 2014; 281: 5009-5022.
6. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 2008; 18: 350-359.
7. Huang Y, Yang YB, Zhang XH, Yu XL, Wang ZB, Cheng XC. MicroRNA-21 gene and cancer. Med Oncol 2013; 30: 376.
8. Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ, Wang YK, Zeng F, Zhou JH, Zhang YK. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol 2012; 29: 618-626.
9. Heegaard NH, Schetter AJ, Welsh JA, Yoneda M, Bowman ED, Harris CC. Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. Int J Cancer 2012; 130: 1378-1386.
10. Liva KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) method. Method 2001; 25: 402-408.
11. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
12. Hammond SM. MicroRNAs as oncogenes. Curr Opin Genet Dev 2006; 16: 4-9.
13. Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, Westra WH. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res 2010; 16: 610-619.
14. Corsini LR, Bronte G, Terrasi M, Amodeo V, Fanale D, Fiorentino E, Cicero G, Bazan V, Russo A. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies. Expert Opin Ther Targets 2012; Suppl 2: S103-109.
15. Huang GL, Zhang XH, Guo GL, Huang KT, Yang KY, Shen X, You J, Hu XQ. Clinical significance of miR-21 expression in breast cancer: SYBRGreen I-based real-time RT-PCR study of invasive ductal carcinoma. Oncol Rep 2009; 21: 673-9.
16. Huang Y, Yang YB, Zhang XH, Yu XL, Wang ZB, Cheng XC. MicroRNA-21 gene and cancer. Med Oncol 2013; 30: 376.
17. Cui L, Zhang X, Ye G, Zheng T, Song H, Deng H, Xiao B, Xia T, Yu X, Le Y, Guo J. Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer. Cancer 2013; 119: 1618-1626.